Cardiac failure Respiratory failure Cardiogenic shock Critical illness Extracorporeal membrane oxygenation Hospital mortality Cardiogenic shock Heart failure Respiratory insufficiency Critical illness
Conditions
Interventions
Patients that are receiving/initiating ECMO support in Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast from 1 January 2021 to 31 December 2025
Treatment
Critically ill ECMO patients
Sponsors
Khunatch Laowattanakul
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients that are receiving/initiating ECMO support in Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast from 1 January 2021 to 31 December 2025
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall in-hospital mortality From hospital admission to hospital discharge Percentage and Mean survival time | — |
Secondary
| Measure | Time frame |
|---|---|
| Indication for ECMO support At the time of ECMO initiation Clinical indications classified by Extracorporeal Life Support Organization guidelines including cardiac failure pulmonary failure and extracorporeal cardiopulmonary resuscitation,Complications from ECMO support During ECMO therapy until hospital discharge Frequency of adverse events including circuit problems hemorrhage neurological complications acute kidney injury and other related clinical complications | — |
Countries
Thailand
Contacts
Public ContactKhunatch Laowattanakul
Faculty of Medicine, Khon Kaen University
Outcome results
None listed